≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Laparoscopic right hemicolectomy

Endpoint Browser

OPER_JFB31

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Operations: NOMESCO codes — ^JFB31

1 out of 7 registries used, show all original rules.

1876

4. Check minimum number of events

None

1876

5. Include endpoints

None

1876

6. Filter based on genotype QC (FinnGen only)

1876

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1876 971 905
Unadjusted period prevalence (%) 0.36 0.33 0.40
Median age at first event (years) 71.96 71.84 72.09

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1581
Matched controls
15810
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
261.8
323.0
394
20
UJF32
NOMESCO Finland
Coloscopy
10.5
323.0
1146
3171
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
288.2
323.0
482
24
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
248.1
323.0
507
30
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
223.9
323.0
363
21
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
+∞
323.0
1581
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
123.8
307.1
325
33
L01BC06
ATC
capecitabine; oral
19.6
260.3
412
279
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
121.5
239.5
255
25
130
Kela drug reimbursment
Malignant tumour
8.6
210.6
521
858
B01AB05
ATC
enoxaparin; parenteral
5.4
210.0
990
3757
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
29.2
172.6
237
95
JN4BD
NOMESCO Finland
Extensive body CT
6.3
170.5
536
1193
C18.31
ICD-10 Finland
Malignant tumor of flexura hepatica invasive carcinoma
150.5
143.0
150
11
TPH07
NOMESCO Finland
Cathetrisation of artery
5.6
134.5
454
1059
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
6.7
126.3
359
668
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
73.0
123.0
140
21
WX402
NOMESCO Finland
General anaesthesia
4.5
117.2
496
1447
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
12.2
113.5
215
201
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
10.2
111.7
233
263
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.7
111.5
279
427
WZC30
NOMESCO Finland
Teaching
4.3
101.1
444
1316
JN4AD
NOMESCO Finland
Body CT examination
5.1
91.4
326
773
A04AA02
ATC
granisetron; systemic, transdermal
6.1
91.3
273
526
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
7.9
90.5
220
317
A03FA01
ATC
metoclopramide; systemic, rectal
3.4
89.8
557
2176
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
92.9
87.1
96
11
D64.9
ICD-10 Finland
Anaemia, unspecified
4.1
84.9
385
1152
C18.29
ICD-10 Finland
Malignant tumor of the ascending colon or other unspecified histology
77.5
84.3
95
13
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
7.3
83.7
214
331
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
83.3
652
2973
C18.30
ICD-10 Finland
Malignant tumor of flexura hepatica without histology
71.2
82.4
94
14
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.2
82.0
238
438
B01AB10
ATC
tinzaparin; parenteral
5.3
81.0
272
597
C18.02
ICD-10 Finland
Malignant tumor of caecum carcinoma of adenoma
108.0
75.7
82
8
UJF30
NOMESCO Finland
Ileoscopy through colon
4.1
69.7
304
862
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
47.1
69.7
85
19
C18.2
ICD-10 Finland
Malignant neoplasm: Ascending colon
110.8
68.5
74
7
C18.22
ICD-10 Finland
Malignant tumor of the colon ascending carcinoma of the adenoma
94.3
65.5
72
8
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
10.5
65.0
131
135
8140/3-C18.3
ICD-O-3
Adenocarcinoma, NOS, of hepatic flexure of colon
116.5
62.3
67
6
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
65.5
59.9
69
11
ZXE20
NOMESCO Finland
More than three and less than five hours
3.1
59.5
379
1439
C18.11
ICD-10 Finland
Malignant tumor of the appendix invasive carcinoma
49.4
58.8
71
15
H02AB02
ATC
dexamethasone; systemic
3.6
58.1
299
966
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.5
57.6
673
3668
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
6.6
56.1
152
251
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
4.7
55.9
205
485
C18.0
ICD-10 Finland
Malignant neoplasm: Caecum
44.3
55.2
68
16
C18.10
ICD-10 Finland
Malignant tumor of the appendix without histology
48.7
50.5
61
13
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
49.6
633
3534
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.1
48.5
164
354
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.1
47.0
196
522
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
45.5
715
4345
N02BE01
ATC
paracetamol; systemic, rectal
3.0
44.5
1438
12140
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
8.5
44.1
99
123
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
7.1
44.0
112
169
C18.19
ICD-10 Finland
Malignant tumor in appendix other or unspecified histology
56.1
41.6
49
9
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
6.4
41.6
114
190
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
7.2
40.8
102
150
8140/3-C18.4
ICD-O-3
Adenocarcinoma, NOS, of transverse colon
32.2
40.3
53
17
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.9
39.2
268
1038
D75
ICPC
Malignant neoplasm colon/rectum
13.8
37.4
65
49
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
27.1
36.5
50
19
WX290
NOMESCO Finland
Other blockade of nerve
2.1
36.4
617
3761
8480/3-C18.0
ICD-O-3
Mucinous adenocarcinoma of cecum
82.1
36.0
40
5
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
4.3
35.5
139
347
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
4.1
35.4
146
382
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
34.9
397
2026
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.6
34.3
166
499
ZX120
NOMESCO Finland
Intravenous
2.7
30.4
228
926
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
30.3
412
2259
C18
ICD-10 Finland
Malignant neoplasm of colon
84.3
29.8
33
*
8480/3-C18.2
ICD-O-3
Mucinous adenocarcinoma of ascending colon
158.0
29.8
31
*
B80
ICPC
Iron deficiency anaemia
6.6
29.4
77
121
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
4.3
29.3
112
273
JN4CD
NOMESCO Finland
Very extensive body CT
3.8
28.5
127
356
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
24.1
28.4
40
17
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.1
28.4
115
296
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
18.4
28.0
43
24
WX110
NOMESCO Finland
Local anesthesy
1.8
26.9
1046
8211
C18.39
ICD-10 Finland
Malignant tumor of flexura hepatica other or unspecified histology
91.6
24.7
27
*
JFB33
NOMESCO Finland
Other resection comprising small intestine and colon
68.5
23.9
27
*
A02BC02
ATC
pantoprazole; systemic
1.7
23.5
1065
8566
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
11.3
23.4
44
40
JN3AD
NOMESCO Finland
Abdominal CT examination
2.7
23.4
177
717
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
3.7
23.1
106
304
8263/2-C18.0
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of cecum
233.2
22.7
23
*
WX704
NOMESCO Finland
Intubation
2.8
22.0
149
565
D50
ICD-10 Finland
Iron deficiency anaemia
6.0
21.3
59
101
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.9
20.1
356
2112
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
6.6
19.7
51
80
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.0
19.4
54
93
L01BC59
ATC
trifluridine, combinations; systemic
31.7
19.3
25
8
JEA01
NOMESCO Finland
Laparoscopic appendectomy
4.7
18.9
65
143
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.3
18.7
70
168
C18.12
ICD-10 Finland
Malignant tumor of the appendix carcinoma of the adenoma
101.3
18.6
20
*
B82
ICPC
Anaemia other/unspecified
4.0
18.3
74
191
C18.91
ICD-10 Finland
Malignant tumor of unspecified location in colon invasive carcinoma
44.5
18.3
22
5
E0000UV
ATC
NA
1.6
18.2
606
4341
UJF32
SPAT
NA
5.8
17.8
50
88
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
5.6
17.6
51
93
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
24.3
17.3
24
10
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
12.1
17.3
31
26
D12.1
ICD-10 Finland
Benign neoplasm: Appendix
17.6
16.9
26
15
C18.32
ICD-10 Finland
Malignant tumor of flexura hepatica carcinoma of adenoma
+∞
16.7
16
*
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
23.3
16.4
23
10
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
16.2
521
3668
K63.5
ICD-10 Finland
Polyp of colon
6.2
16.1
43
71
C18.1
ICD-10 Finland
Malignant neoplasm: Appendix
48.0
16.0
19
*
Z31.5
ICD-10 Finland
Genetic counselling
3.6
16.0
74
215
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
16.0
751
5810
A98
ICPC
Health maint/preventive medicine
2.2
15.8
1477
13699
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
19.4
15.6
23
12
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
4.5
15.5
55
126
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
5.5
15.0
44
82
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
6.7
14.8
37
56
C18.3
ICD-10 Finland
Malignant neoplasm: Hepatic flexure
80.9
14.6
16
*
8480/3-C18.3
ICD-O-3
Mucinous adenocarcinoma of hepatic flexure of colon
151.3
14.5
15
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
14.3
617
4634
1XC07
NOMESCO Finland
NA
17.1
14.3
22
13
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
4.2
14.2
53
128
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
5.2
14.0
43
85
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.3
14.0
71
223
8240/3-C17.2
ICD-O-3
Neuroendocrine tumor, NOS, of ileum
20.2
13.8
20
10
R4110
NOMESCO Finland
Physiotherapy
1.6
13.7
436
3035
8480/3-C18.9
ICD-O-3
Mucinous adenocarcinoma of colon, NOS
+∞
13.6
13
*
8140/3-C18.1
ICD-O-3
Adenocarcinoma, NOS, of appendix
141.2
13.5
14
*
K35.9
ICD-10 Finland
Acute appendicitis, unspecified
2.6
13.0
96
385
8240/3-C18.1
ICD-O-3
Neuroendocrine tumor, NOS, of appendix
28.6
13.0
17
6
3AC01
NOMESCO Finland
NA
5.2
12.9
39
76
JJB10
NOMESCO Finland
Atypcal resection of liver
15.6
12.6
20
13
C18.9
ICD-10 Finland
Malignant neoplasm: Colon, unspecified
70.4
12.6
14
*
Z51.5
ICD-10 Finland
Palliative care
2.2
12.5
131
625
176
Kela drug reimbursment
Regorafenib
17.5
12.5
19
11
JAH00
NOMESCO Finland
Laparotomy
3.2
12.4
64
204
A04AA01
ATC
ondansetron; systemic, rectal
2.2
12.2
122
571
K92.1
ICD-10 Finland
Melaena
2.4
11.9
105
464
C18.49
ICD-10 Finland
Malignant tumor of the transverse colon other or unspecified histology
47.0
11.9
14
*
JFB30
NOMESCO Finland
Right hemicolectomy
4.2
11.8
44
107
8244/3-C18.1
ICD-O-3
Mixed adenoneuroendocrine carcinoma of appendix
120.9
11.4
12
*
A04AD12
ATC
aprepitant; systemic
3.8
11.4
47
126
SPAT1131
SPAT
Colonoscopy
2.8
11.1
71
263
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.4
11.1
91
388
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.3
11.0
99
441
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.2
10.9
116
559
8249/3-C17.2
ICD-O-3
Neuroendocrine tumor, grade 2 of ileum
43.6
10.9
13
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.7
10.8
75
288
369
Kela drug reimbursment
Regorafenib
15.6
10.8
17
11
K56.7
ICD-10 Finland
Ileus, unspecified
4.0
10.6
41
104
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
10.1
10.5
20
20
ZXE00
NOMESCO Finland
One hour or less
1.4
10.5
579
4505
8243/3-C18.1
ICD-O-3
Goblet cell carcinoid of appendix
+∞
10.4
10
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
10.4
131
676
C18.4
ICD-10 Finland
Malignant neoplasm: Transverse colon
32.7
10.3
13
*
RD211
NOMESCO Finland
NA
2.5
10.3
79
323
JFA42
NOMESCO Finland
Endoscopic injection in colon
8.9
10.3
21
24
JWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery
18.9
10.3
15
8
D64.8
ICD-10 Finland
Other specified anaemias
3.7
10.2
44
123
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
5.4
10.0
29
55
D37.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Appendix
16.8
9.9
15
9
JJB71
NOMESCO Finland
Laparoscopic resection of liver
16.8
9.9
15
9
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
6.0
9.8
26
44
D12.7
ICD-10 Finland
Benign neoplasm: Rectosigmoid junction
4.5
9.7
33
75
SPAT1153
SPAT
Removal of sutures
1.4
9.5
526
4073
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.8
9.4
38
101
JFC10
NOMESCO Finland
Ileotransversostomy
+∞
9.4
9
*
Z3226
NOMESCO Finland
Physiotherapist
1.6
9.3
286
1954
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
9.2
158
912
Z3231
NOMESCO Finland
Registered nurse
1.5
9.2
416
3091
WW500
NOMESCO Finland
Blood transfusion
2.4
9.2
76
326
D50.8
ICD-10 Finland
Other iron deficiency anaemias
4.1
9.1
34
85
ZX100
NOMESCO Finland
Oral
3.9
9.0
36
95
R4190
NOMESCO Finland
Nutritional therapy
3.0
9.0
51
174
S18
ICPC
Laceration/cut
1.4
8.8
662
5400
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
8.8
138
776
WX002
NOMESCO Finland
Sedation and analgesia
1.5
8.7
323
2302
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
8.3
8.6
18
22
Z93.2
ICD-10 Finland
Ileostomy status
10.1
8.5
16
16
C18.42
ICD-10 Finland
Malignant tumor of the transverse colon carcinoma of the adenoma
27.7
8.5
11
*
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
8.4
383
2846
JFF10
NOMESCO Finland
Loop enterostomy
5.9
8.3
22
38
SPAT1255
SPAT
Intravenous administration of medicine
2.0
8.3
107
559
XX3DW
NOMESCO Finland
Time consuming IT work
1.7
8.3
173
1062
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
8.3
145
847
K35.1
ICD-10 Finland
Acute appendicitis with peritoneal abscess
4.7
8.1
26
56
WZA10
NOMESCO Finland
Long statement of health and health related matters
4.1
8.1
30
75
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.7
8.1
33
90
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
10.1
8.0
15
15
A04AA55
ATC
palonosetron, combinations; systemic
2.9
7.8
45
157
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.1
7.8
86
422
8480/3-C18.1
ICD-O-3
Mucinous adenocarcinoma of appendix
15.1
7.7
12
8
Z2221
NOMESCO Finland
Medical doctor
1.4
7.6
384
2901
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.9
7.5
43
149
8263/2-C18.2
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of ascending colon
80.5
7.4
8
*
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
7.7
7.4
16
21
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
7.3
270
1915
H01CB03
ATC
lanreotide; parenteral
9.4
7.3
14
15
TJX00
NOMESCO Finland
Punkture or biopsy in gastrointestinal endoscopy
15.8
7.2
11
7
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.1
7.0
36
119
WW200
SPAT
NA
0.4
6.9
35
779
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
6.8
48
190
Z51.4
ICD-10 Finland
Preparatory care for subsequent treatment, not elsewhere classified
4.2
6.8
24
58
8140/3-C18.8
ICD-O-3
Adenocarcinoma, NOS, of overlapping lesion of colon
40.2
6.8
8
*
JAH01
NOMESCO Finland
Laparoscopy
2.2
6.7
62
284
V03AF03
ATC
calcium folinate; systemic
12.3
6.6
11
9
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
10.1
6.5
12
12
WX306
NOMESCO Finland
Lumbar epidural anesthesy
2.2
6.4
65
309
C180, 8211, 2
ICD-O-3
NA
70.1
6.4
7
*
JFA52
NOMESCO Finland
Other endoscopic haemostatic procedure in colon
7.4
6.4
14
19
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
5.5
6.3
17
31
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
9.3
6.3
12
13
JJB30
NOMESCO Finland
Excision of two segments of liver
18.1
6.3
9
5
8211/2-C18.2
ICD-O-3
Tubular adenocarcinoma in situ of ascending colon
+∞
6.3
6
*
JFA98
SPAT
NA
+∞
6.3
6
*
B01AB04
ATC
dalteparin; parenteral
1.9
6.2
85
459
L01XE21
ATC
[U] regorafenib; oral
12.6
6.1
10
8
P01AB01
ATC
metronidazole; oral, rectal
1.3
6.1
507
4144
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.4
6.0
20
46
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
6.0
231
1649

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1608
1955
51.58
307.65
7.9
3.8
ug/l
5.5
22.6
2.70
1460
1606
(3022145) Colonoscopy Study observation
979
1772
10.46
307.65
1.4
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
405
704
7.06
232.52
4.6
3.1
u/ml
139.3
5988.0
0.85
365
595
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1112
4525
4.58
231.74
2.5
2.2
mg/l
4.2
3.1
16.91
985
3816
(3022948) Iron [Moles/volume] in Serum or Plasma
823
2815
4.43
213.64
2.3
2.5
umol/l
10.3
12.4
8.81
790
2598
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
763
2467
4.53
213.60
2.2
2.6
%
16.8
22.2
17.40
694
2100
(3004789) Transferrin [Mass/volume] in Serum or Plasma
784
2601
4.46
211.77
2.2
2.5
g/l
2.5
2.3
26.35
762
2403
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1465
7796
5.01
201.09
4.7
4.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1449
7743
4.83
195.17
6.7
4.8
g/l
34.7
34.8
0.27
1405
7170
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1274
6479
4.01
177.11
3.3
2.8
ug/l
82.7
149.6
18.30
1180
5870
(3044640) Blood type and Crossmatch panel - Blood
1133
5405
3.77
171.90
2.7
2.6
—
—
—
0
0
(4035726)
521
1552
4.26
156.88
1.4
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
910
4196
3.27
137.09
2.5
2.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1453
8934
3.78
133.05
10.2
6.2
umol/l
10.8
11.9
3.47
1422
8473
(3033658) Prothrombin time (PT) actual/Normal
898
4287
3.10
124.38
4.5
4.0
%
90.6
86.0
5.56
885
4188
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
504
1704
3.68
123.63
2.2
2.1
g/l
0.2
0.2
3.80
490
1592
(40768804) Tissue Pathology biopsy report
1140
6448
2.96
112.19
2.6
2.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
214
408
5.79
108.74
4.7
3.1
u/ml
57.7
997.1
0.86
202
375
(3013650) Neutrophils [#/volume] in Blood by Automated count
1398
9322
2.96
92.66
12.5
9.0
e9/l
4.0
4.2
3.21
1214
8085
(3013826) Glucose [Moles/volume] in Serum or Plasma
1448
10084
2.91
83.66
5.6
4.9
mmol/l
6.8
6.9
0.20
1395
9505
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1686
12819
4.11
83.45
12.2
7.8
u/l
83.6
79.8
2.45
1649
12018
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
308
1009
3.46
76.51
6.7
9.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
524
2337
2.72
75.34
1.2
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
741
4002
2.41
70.17
1.3
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
481
2251
2.53
61.05
1.9
2.5
%
1.8
1.8
0.17
422
1979
(3032080) INR in Blood by Coagulation assay
1126
7562
2.22
60.17
9.8
10.8
inr
1.3
1.3
0.62
349
2090
(3014007) Fractional oxyhemoglobin in Arterial blood
308
1182
2.92
57.56
7.9
8.7
%
95.2
94.0
4.49
308
1174
(3003396) Base excess in Arterial blood by calculation
464
2198
2.48
56.90
6.6
7.0
mmol/l
0.4
1.1
4.45
378
1711
(3027801) Oxygen [Partial pressure] in Arterial blood
461
2195
2.46
55.78
6.8
7.0
kpa
13.8
12.0
11.28
453
2089
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
461
2195
2.46
55.78
6.8
7.0
kpa
5.2
5.1
3.48
453
2087
(3014576) Chloride [Moles/volume] in Serum or Plasma
486
2375
2.41
55.47
6.7
6.5
mmol/l
105.9
104.2
14.93
479
2312
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1246
8942
2.17
53.23
7.6
7.0
mmol/l
1.2
1.2
4.45
1060
7533
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
845
5308
2.08
50.75
2.7
2.5
u/l
55.9
57.7
0.63
808
4881
(3014111) Lactate [Moles/volume] in Serum or Plasma
364
1647
2.50
48.53
6.5
6.5
mmol/l
1.1
1.4
5.98
350
1585
(3006315) Basophils [#/volume] in Blood
1128
7996
2.03
47.12
5.1
5.6
e9/l
0.0
0.0
0.17
939
6802
(3006504) Eosinophils/100 leukocytes in Blood
1074
7507
2.01
46.38
5.3
5.9
%
2.8
2.8
0.06
1006
6959
(3001604) Monocytes [#/volume] in Blood
1121
7963
2.01
46.13
5.0
5.6
e9/l
0.6
0.6
0.31
929
6758
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1145
8195
2.02
46.11
6.8
6.0
mmol/l
1.2
1.2
2.51
1077
7372
(3019069) Monocytes/100 leukocytes in Blood
1076
7539
2.00
46.00
5.5
6.2
%
9.1
8.9
1.05
1008
7019
(3022096) Basophils/100 leukocytes in Blood
1052
7314
2.00
45.97
5.4
5.9
%
0.7
0.7
0.09
984
6793
(3019198) Lymphocytes [#/volume] in Blood
1135
8131
2.00
45.18
5.2
5.7
e9/l
1.7
1.9
2.90
966
7042
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
616
3560
2.09
45.14
6.6
3.0
mmol/l
2.5
2.5
0.55
564
3134
(3018010) Neutrophils/100 leukocytes in Blood
1072
7534
1.99
45.04
5.2
5.8
%
59.4
58.3
2.48
1006
7008
(3002030) Lymphocytes/100 leukocytes in Blood
1084
7666
1.98
44.51
5.5
6.1
%
25.1
26.5
3.82
1012
7092
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1790
15551
4.30
44.32
24.2
16.7
mg/l
36.3
26.0
26.28
1713
12635
(3013115) Eosinophils [#/volume] in Blood
1144
8254
1.99
44.17
5.2
5.8
e9/l
0.2
0.2
0.16
968
7131
(3021589) Normoblasts [#/volume] in Blood
1012
7008
1.96
43.99
13.8
10.4
e9/l
0.0
0.0
0.08
812
5687
(3023520) Reticulocytes [#/volume] in Blood
363
1715
2.38
43.61
1.9
2.5
e9/l
68.9
69.0
0.02
267
1323
(3000991) Gas panel - Venous blood
336
1546
2.43
42.77
7.2
7.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
379
1867
2.29
41.12
2.9
2.6
umol/l
7.0
9.0
1.82
335
1639
(3023368) Bacteria identified in Blood by Culture
793
5154
1.93
40.60
4.6
4.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
895
6084
1.90
39.69
5.9
3.4
mmol/l
2.4
2.4
0.78
808
5228
(42870588) Differential panel, method unspecified - Blood
847
5664
1.90
39.44
4.8
5.6
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
28
12
23.67
38.70
1.0
1.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1827
16432
5.28
35.87
29.6
20.0
mmol/l
139.4
139.6
3.06
1813
16021
(3023103) Potassium [Moles/volume] in Serum or Plasma
1829
16470
5.41
35.70
29.7
20.1
mmol/l
4.0
4.0
5.68
1813
16041
(3002385) Erythrocyte distribution width [Ratio]
1510
12453
2.09
34.75
32.9
20.5
%
14.8
13.9
56.20
1495
12169
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
317
1580
2.21
32.83
2.6
2.3
u/l
35.9
39.3
0.36
278
1337
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
279
1323
2.30
32.57
1.6
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1696
14773
2.54
32.25
25.0
15.9
ml/min/173m2
76.0
74.3
3.20
1520
12234
(3002256) Pathology report gross observation
393
2144
2.05
32.12
1.4
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
215
922
2.50
31.38
1.3
1.8
g/l
1.8
1.5
3.27
185
802
(40758558) Short blood count panel - Blood
627
4070
1.81
29.99
9.2
6.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1812
16481
3.92
29.05
16.3
11.4
u/l
24.9
25.0
0.05
1785
15810
(40761511) CBC panel - Blood by Automated count
1770
15916
2.98
28.32
25.6
16.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
160
629
2.69
27.82
4.4
2.9
g/l
0.2
0.3
2.77
101
234
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1006
7605
1.70
27.11
2.2
2.1
pmol/l
92.7
94.0
0.39
588
3884
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
716
4954
1.72
26.71
3.8
3.1
u/l
33.2
35.8
0.57
686
4691
(3044889) 12 lead EKG panel
1400
11618
1.81
26.66
4.7
4.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1835
16931
4.83
26.65
40.2
24.8
e9/l
253.5
243.7
7.29
1797
16442
(3024731) MCV [Entitic volume]
1835
16933
4.83
26.60
40.1
24.7
fl
90.7
91.7
12.24
1825
16634
(3035941) MCH [Entitic mass]
1835
16934
4.83
26.58
40.1
24.6
pg
29.8
30.4
28.31
1825
16633
(3026361) Erythrocytes [#/volume] in Blood
1835
16935
4.82
26.55
40.2
24.7
e12/l
4.3
4.4
15.86
1791
16390
(3000963) Hemoglobin [Mass/volume] in Blood
1835
16938
4.81
26.48
40.6
24.9
g/l
126.6
133.4
63.25
1826
16644
(3010813) Leukocytes [#/volume] in Blood
1835
16938
4.81
26.48
40.3
24.8
e9/l
6.9
6.8
0.41
1792
16395
(3021960) Folate [Moles/volume] in Serum or Plasma
666
4529
1.73
26.37
1.6
1.6
nmol/l
20.9
20.3
0.42
586
3793
(3002582) Erythrocytes [#/volume] in Urine
758
5348
1.70
26.17
3.5
3.4
e6/l
40.0
86.7
2.39
574
4179
(3018095) Leukocytes [#/volume] in Urine
841
6107
1.68
26.00
4.2
3.9
e6/l
92.0
125.7
0.80
605
4467
(3018418) pH of Serum or Plasma
754
5359
1.68
25.01
4.4
4.1
ph
7.4
7.4
1.03
166
1016
(3031040) Bacteria [#/volume] in Urine by Automated count
1337
11050
1.73
24.61
4.9
5.1
e6/l
420.1
2108.2
1.64
16
181
(3030467) Casts [#/volume] in Urine by Automated count
701
4923
1.68
24.11
3.3
3.3
e6/l
0.6
0.5
0.47
520
3786
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
207
984
2.24
23.70
2.6
2.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
79
234
3.48
22.45
2.3
2.2
u/ml
4.0
1298.6
0.60
74
227
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
471
3024
1.74
22.22
1.3
1.2
u/ml
2.1
1.4
0.40
121
748
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
445
2850
1.74
21.02
3.3
3.1
e6/l
3.0
2.2
0.82
240
1602
(36304419) Bacteria [Presence] in Urine
663
4724
1.62
20.78
3.3
3.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
361
2183
1.81
20.75
3.0
3.9
u/l
222.5
250.1
4.34
341
2056
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1153
9422
1.58
19.69
3.5
3.2
u/l
58.7
54.3
0.69
1080
8593
(3037467) Urinalysis macro (dipstick) panel - Urine
1330
11331
1.60
18.16
5.0
4.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1526
13484
1.71
17.68
28.7
18.3
%
37.2
38.8
7.41
1001
8501
(3007164) IgA [Mass/volume] in Serum or Plasma
415
2721
1.67
17.59
1.3
1.5
g/l
2.5
2.6
0.52
223
1568
(3019309) Folate [Moles/volume] in Red Blood Cells
534
3738
1.60
17.38
1.7
1.8
nmol/l
1216.1
1177.0
0.40
379
2786
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
147
690
2.23
17.26
1.8
2.7
u/ml
0.3
0.4
0.22
76
408
(3013707) Erythrocyte sedimentation rate by Westergren method
1386
12008
1.59
16.79
4.2
4.3
mm/h
16.5
13.9
6.81
1262
11003
(3020779) Urea [Moles/volume] in Serum or Plasma
276
1680
1.75
15.17
5.1
7.0
mmol/l
9.8
10.7
1.36
268
1598
(3012095) Magnesium [Moles/volume] in Serum or Plasma
429
2933
1.60
15.10
3.1
3.2
mmol/l
0.8
0.8
0.49
403
2733
(3026782) Osmolality of Urine
501
3558
1.56
14.94
2.8
2.9
mosm/kgh2o
553.8
545.9
0.35
434
3031
(3048689) Calprotectin [Mass/mass] in Stool
261
1613
1.72
13.51
2.0
2.1
ug/g
185.3
150.1
0.50
204
1269
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1696
15703
1.83
13.45
5.1
5.4
mmol/l
2.5
2.6
4.94
1536
14156
(3018677) aPTT in Platelet poor plasma by Coagulation assay
402
2776
1.57
13.37
2.0
2.0
s
30.4
30.0
0.74
390
2688
(40760892) CBC W Ordered Manual Differential panel - Blood
446
3166
1.54
13.08
4.1
4.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1667
15416
1.73
12.48
5.1
5.1
mmol/l
6.2
6.1
1.68
1511
13779
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1619
14869
1.65
12.30
6.6
6.5
mmol/mol
41.0
40.7
0.45
1484
13548
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
428
3058
1.52
12.05
3.1
2.9
e6/l
1.4
1.3
0.09
221
1797
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
485
3567
1.49
11.84
3.8
4.1
ng/l
652.9
392.9
0.22
415
3026
(3035350) Ketones [Presence] in Urine by Test strip
946
7864
1.41
11.84
3.8
4.1
estimate
0.0
0.0
0.00
218
1489
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
832
6775
1.41
11.67
2.3
2.2
nmol/l
78.1
79.2
0.54
757
5935
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
288
1922
1.59
10.92
4.1
3.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
217
1350
1.69
10.89
3.3
4.1
%
0.0
0.1
1.67
71
407
(3000850) Epithelial cells [#/volume] in Urine
505
3799
1.45
10.83
2.5
2.7
e6/l
5.5
5.6
0.02
436
3343
(3017181) Myelocytes/100 leukocytes in Blood
226
1427
1.66
10.71
3.2
4.1
%
0.9
0.9
0.04
76
444
(3021601) Nitrite [Presence] in Urine by Test strip
940
7893
1.38
10.62
5.2
5.5
estimate
0.0
0.0
0.50
228
1488
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1560
14328
1.53
10.46
4.8
4.9
mu/l
2.0
2.1
0.59
1405
12864
(3025159) Blasts/100 leukocytes in Blood
205
1271
1.69
10.41
3.3
4.1
%
0.1
0.3
0.37
59
348
(3009261) Glucose [Presence] in Urine by Test strip
947
7990
1.37
10.24
3.9
4.1
estimate
0.0
0.0
0.30
228
1451
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
234
1509
1.63
10.20
4.0
3.9
mmol/l
1.2
1.2
0.06
213
1313
(3022217) INR in Platelet poor plasma by Coagulation assay
363
2593
1.50
10.04
27.9
28.3
inr
1.3
1.4
0.91
39
349
(3026008) Bacteria identified in Urine by Culture
702
5667
1.38
9.87
3.2
3.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1642
15303
1.59
9.76
4.4
4.8
mmol/l
4.4
4.5
3.37
1485
13882
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1629
15160
1.57
9.68
4.4
4.8
mmol/l
1.4
1.5
1.08
1468
13641
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
110
580
1.95
9.53
1.3
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
718
5850
1.37
9.41
2.8
3.1
ng/l
1662.5
1542.2
0.30
611
5075
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
54
217
2.53
9.08
1.3
1.3
nmol/l
0.4
0.5
—
5
13
(3002179) Metamyelocytes/100 leukocytes in Blood
202
1297
1.62
8.94
3.1
4.0
%
0.7
0.6
0.16
52
322
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
905
7694
1.34
8.79
2.4
2.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
95
492
1.98
8.68
1.3
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
335
2423
1.47
8.60
4.6
5.6
mmol/l
1.0
1.0
0.16
308
2229
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
821
6897
1.34
8.57
3.8
4.1
ng/l
30.4
62.7
2.25
632
5289
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1578
14670
1.48
8.55
4.0
4.3
mmol/l
1.3
1.3
3.13
1401
13066
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
455
3488
1.40
8.48
1.6
1.7
mg/l
1.4
1.4
0.14
360
2734
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
497
3897
1.37
8.02
1.8
1.7
pmol/l
52130764.1
22110984.7
0.44
399
3184
(3019060) Gas panel - Arterial blood
197
1297
1.58
7.85
5.5
4.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
171
1089
1.63
7.82
1.2
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
202
1339
1.57
7.81
3.8
2.9
ml/min/173m2
60.7
60.7
0.01
86
569
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
48
198
2.46
7.69
1.3
1.2
—
—
—
0
0
(3013512) EKG study
647
5345
1.32
7.25
4.5
4.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
46
192
2.43
7.21
1.3
1.3
nmol/l
—
—
—
0
0
(40768441) Liver Pathology biopsy report
33
117
2.85
7.12
1.1
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
103
590
1.79
6.96
5.5
6.1
mmol/l
1.3
1.3
0.26
98
514
(3041096) Erythrocytes [Presence] in Urine by Automated
504
4063
1.33
6.59
4.3
3.9
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
47
207
2.30
6.56
1.1
1.1
g/l
1.5
1.6
0.33
47
186
(3021447) Carbon dioxide [Partial pressure] in Venous blood
247
1772
1.45
6.54
3.0
3.5
kpa
5.7
5.8
1.70
241
1721
(3036489) Thrombin time
98
573
1.75
6.20
1.7
1.9
s
21.0
21.8
1.03
88
515
(3013139) Helicobacter pylori Ag [Presence] in Stool
156
1042
1.54
5.85
1.2
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
136
882
1.58
5.81
2.9
3.6
mmol/l
23.9
24.1
0.27
131
791
(3025941) Bacteria identified in Stool by Culture
125
803
1.60
5.56
1.2
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
178
1237
1.48
5.55
1.8
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
395
3143
1.33
5.55
1.9
1.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
89
524
1.73
5.53
1.5
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
89
525
1.73
5.50
3.0
3.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
239
1762
1.41
5.44
3.0
3.5
mmol/l
1.6
2.0
0.61
189
1419
(3042936) Bacteria identified in Isolate by Culture
322
2494
1.35
5.42
1.9
2.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
194
1385
1.45
5.27
4.8
4.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
88
525
1.71
5.23
1.3
1.5
ug/g
253.8
275.5
0.45
48
311
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
157
1085
1.49
5.04
1.4
1.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
201
1466
1.42
4.87
2.7
2.8
kpa
4.5
4.5
0.03
195
1419
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
85
523
1.65
4.55
1.6
1.7
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
20
72
2.80
4.29
1.1
2.2
mg/l
52.3
63.1
0.69
15
47
(3017143) Hepatitis C virus Ab [Presence] in Serum
177
1296
1.40
4.21
1.4
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
68
405
1.70
4.13
2.1
2.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
43
228
1.91
3.84
1.6
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
68
414
1.67
3.83
4.9
5.3
mmol/l
2.4
2.7
0.35
51
295
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
43
229
1.90
3.79
1.6
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
275
2189
1.30
3.79
1.7
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
274
2182
1.30
3.76
1.7
1.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1267
11850
1.21
3.71
4.0
4.0
pmol/l
14.9
15.1
1.16
1120
10574
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
421
3548
1.24
3.61
3.4
3.3
ug/l
0.7
0.8
1.47
313
2505
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
42
226
1.88
3.61
1.5
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
67
415
1.64
3.56
1.6
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
179
1355
1.35
3.50
1.4
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
15
53
2.84
3.36
2.5
2.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
67
424
1.60
3.29
2.7
4.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
62
385
1.63
3.28
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
41
227
1.82
3.25
1.6
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
41
227
1.82
3.25
1.6
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
33
170
1.96
3.25
1.1
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
502
4359
1.21
3.17
4.5
4.5
estimate
0.0
0.0
0.69
210
1426
(3005988) Vibrio sp identified in Specimen by Organism specific culture
41
229
1.81
3.17
1.6
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
526
4597
1.20
3.09
3.1
3.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
55
337
1.65
3.09
1.1
1.1
u/ml
3.0
7.2
0.53
11
22
(3023183) Ammonium ion [Moles/volume] in Plasma
59
369
1.62
3.06
2.7
2.5
umol/l
28.7
34.0
1.37
52
310
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
687
6153
1.18
3.06
5.4
5.4
ug/l
3.7
3.3
0.15
615
5452
(4268621)
26
126
2.08
3.03
2.5
2.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
767
1.42
2.94
2.1
2.7
g/l
3.7
3.8
0.26
67
555
(3035637) Corticotropin [Mass/volume] in Plasma
34
184
1.86
2.92
1.4
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
768
1.42
2.92
2.1
2.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
768
1.42
2.92
2.1
2.7
g/l
7.5
7.4
0.20
71
574
(1761482) Bacteria [#/volume] in Urine by Culture
74
494
1.52
2.92
3.1
4.9
—
—
—
0
0
(3000012) Reticulocyte production index
21
95
2.22
2.90
1.1
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
112
814
1.40
2.85
2.1
2.0
ug/l
2.2
2.1
0.03
101
723
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
33
180
1.85
2.78
1.2
1.2
u/ml
1.9
5.7
1.50
16
80
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
38
217
1.77
2.77
1.2
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
35
195
1.81
2.76
1.3
1.3
pmol/l
244.6
285.8
0.68
28
148
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
22
104
2.13
2.75
1.2
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
22
104
2.13
2.75
1.2
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
31
167
1.87
2.72
1.1
1.2
u/l
102.8
51.4
1.01
24
118
(3033799) Differential panel - Peritoneal fluid
15
60
2.51
2.70
1.8
2.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
236
1925
1.26
2.70
1.4
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
65
430
1.53
2.69
1.2
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
236
1934
1.25
2.59
1.7
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
27
489
0.55
2.58
1.7
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
69
470
1.49
2.51
1.1
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
506
4479
1.18
2.51
2.8
2.8
umol/l
5151.5
6713.4
0.35
442
3807
(3045424) Erythrocytes [Presence] in Urine
44
270
1.64
2.51
1.6
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
69
473
1.48
2.44
1.1
1.2
—
—
—
0
0
(3010421) pH of Blood
71
492
1.46
2.39
4.9
4.9
ph
7.4
7.4
0.89
65
409
(40767503) Oxygen content in Capillary blood by calculation
63
427
1.49
2.37
1.9
2.6
%
16.0
15.8
0.10
32
218
(3009508) Creatinine [Moles/volume] in Urine
623
5631
1.16
2.35
3.2
3.2
mmol/l
7.4
7.1
0.88
517
4653
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
17
78
2.19
2.31
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
17
78
2.19
2.31
1.1
1.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
97
716
1.37
2.31
2.0
2.7
g/l
3.1
3.1
0.21
69
568
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
67
463
1.46
2.30
1.1
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
98
726
1.37
2.28
2.1
2.7
g/l
10.7
10.5
0.11
76
615
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
32
186
1.73
2.25
1.2
1.2
u/ml
2.6
3.3
0.14
16
57
(3045414) Leukocytes [Presence] in Urine
100
746
1.36
2.24
2.2
2.0
—
—
—
0
0
(3036603) Volume of Urine
21
107
1.97
2.20
1.3
1.3
ml
2460.4
1758.3
—
5
21
(3004809) Band form neutrophils/100 leukocytes in Blood
47
304
1.56
2.20
3.2
3.8
%
2.4
1.6
0.78
37
239
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
26
143
1.83
2.19
1.0
1.0
u/ml
2.5
2.4
0.05
11
45
(3027456) Digoxin [Moles/volume] in Serum or Plasma
70
493
1.44
2.19
3.6
3.1
nmol/l
0.8
0.8
0.82
56
376
(3011397) Hemoglobin [Presence] in Urine by Test strip
438
3872
1.17
2.19
3.1
4.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
182
1479
1.26
2.18
3.4
3.7
ng/l
104.2
94.4
0.70
161
1256
(3020682) Albumin/Creatinine [Ratio] in Urine
643
5855
1.15
2.16
4.2
4.0
mg/mmol
8.3
8.8
0.13
414
3645
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
550
4958
1.15
2.12
4.5
4.7
%
21.8
21.5
0.16
304
2596
(3017569) Oxygen content in Arterial blood
20
103
1.95
2.05
1.5
2.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
20
104
1.93
2.00
1.3
1.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
88
658
1.35
1.97
2.1
2.8
g/l
0.4
1.4
3.09
69
567
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
14
64
2.20
1.94
3.0
2.5
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
23
127
1.82
1.94
1.1
1.4
g/l
0.5
0.4
0.26
18
88
(3027135) IgG subclass 1 [Mass/volume] in Serum
23
127
1.82
1.94
1.1
1.4
g/l
7.9
7.3
0.24
18
88
(3028192) IgG subclass 2 [Mass/volume] in Serum
23
127
1.82
1.94
1.1
1.4
g/l
3.5
2.8
1.07
18
90
(3049717) Cytology report of Urine Cyto stain
102
783
1.32
1.92
3.6
2.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
82
610
1.36
1.91
2.1
2.6
g/l
36.9
37.2
0.21
60
522
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
21
114
1.85
1.87
1.6
1.4
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
9
34
2.65
1.86
5.9
3.0
ml/dl
12.7
14.6
—
9
29
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
18
93
1.94
1.85
3.3
1.9
%
15.5
15.6
—
8
37
(3008536) Aspergillus sp Ab [Presence] in Serum
10
40
2.51
1.83
1.8
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
605
5538
1.14
1.83
3.3
3.3
mg/l
147.3
287.2
0.63
387
3480
(3004451) EKG impression Narrative
19
101
1.89
1.81
1.1
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
33
207
1.60
1.80
1.2
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
119
944
1.28
1.78
3.5
3.9
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
60
2.17
1.78
1.0
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
49
338
1.46
1.76
1.3
1.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
78
586
1.35
1.73
6.1
3.9
mmol/l
3.9
3.9
0.03
72
538
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
76
569
1.35
1.72
2.1
2.7
g/l
0.4
0.0
0.44
65
524
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
13
61
2.14
1.71
1.2
1.3
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
18
96
1.88
1.70
3.3
1.9
%
72.7
71.9
0.08
18
88
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
42
283
1.50
1.70
1.3
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
17
89
1.92
1.70
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
16
82
1.96
1.69
1.1
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
19
104
1.84
1.67
1.3
1.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
86
660
1.32
1.66
1.9
3.5
ratio
1.5
1.7
—
6
52
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
83
634
1.32
1.66
1.1
1.0
—
—
—
0
0
(3020891) Body temperature
98
770
1.29
1.60
6.6
4.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
207
1765
1.19
1.60
2.6
3.0
ng/l
203.8
223.6
0.34
191
1618
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
647
5990
1.12
1.60
4.5
4.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
16
84
1.91
1.59
1.6
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
16
84
1.91
1.59
1.6
1.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
87
674
1.30
1.58
1.9
3.6
mg/l
109.6
135.5
0.10
82
554
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
18
99
1.83
1.57
1.6
1.6
u/l
0.6
7.6
—
8
51
(4062490)
22
129
1.71
1.57
1.1
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
20
114
1.76
1.56
1.6
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
46
322
1.44
1.56
2.1
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
87
676
1.30
1.55
1.9
3.6
mg/l
34.1
81.6
1.53
82
558
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
45
0.00
1.50
0.0
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
124
1504
0.81
1.46
3.3
3.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
129
1063
1.23
1.44
3.6
3.2
e9/l
4.7
4.1
1.16
93
775
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
16
3.13
1.44
1.2
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
25
156
1.61
1.44
1.2
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
80
623
1.30
1.43
1.1
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
161
1359
1.20
1.41
1.6
1.7
%
1.6
1.6
0.09
136
1136
(3017446) Testosterone [Moles/volume] in Serum or Plasma
128
1056
1.23
1.41
2.2
2.1
nmol/l
11.6
12.7
0.77
106
918
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
238
0.54
1.40
1.7
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
21
126
1.67
1.40
3.6
1.9
e9/l
1.0
1.0
0.06
13
74
(3019977) pH of Arterial blood
19
111
1.72
1.39
1.9
2.9
ph
7.4
7.4
—
9
40
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
16
89
1.80
1.37
3.1
1.8
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
24
151
1.60
1.35
1.4
1.3
—
30.4
—
0
9
(4281824)
29
191
1.53
1.35
1.1
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
47
2.13
1.33
2.7
2.8
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
9
42
2.15
1.33
2.9
2.0
%
29.4
29.1
—
9
37
(3051611) Lipemic interference index of Serum or Plasma
29
192
1.52
1.32
3.1
3.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
18
2.78
1.28
1.6
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
18
2.78
1.28
1.8
1.8
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
109
896
1.23
1.27
2.1
2.4
%
1.1
1.1
0.00
109
888
(3034426) Prothrombin time (PT)
9
44
2.05
1.27
1.2
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
181
1562
1.18
1.26
1.4
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
43
313
1.38
1.23
1.0
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
43
313
1.38
1.23
2.6
3.2
e9/l
3.8
4.4
1.60
43
313
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
69
540
1.29
1.22
2.2
2.7
g/l
0.0
0.0
0.49
58
497
(3020630) Protein [Mass/volume] in Serum or Plasma
187
1623
1.17
1.22
2.4
2.8
g/l
65.9
66.4
0.33
161
1476
(3004588) Protein electrophoresis panel - Serum or Plasma
160
1371
1.18
1.22
2.0
2.6
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
19
2.64
1.21
2.4
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
19
116
1.64
1.21
1.5
2.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
19
116
1.64
1.21
1.0
1.1
u/ml
4.3
5.0
—
7
51
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
124
1.62
1.21
1.3
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
31
213
1.46
1.20
1.4
1.6
%
43.9
65.2
1.69
18
141
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
277
2477
1.14
1.20
1.3
1.3
iu/ml
42.9
40.1
0.11
83
793
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
12
64
1.88
1.18
1.7
1.9
nmol/l
1.3
11.1
0.78
12
54
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
35
485
0.72
1.16
1.7
1.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
8
39
2.06
1.15
1.0
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
19
118
1.62
1.15
1.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
23
150
1.54
1.14
1.1
1.6
%
11.5
10.9
0.34
23
150
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
35
250
1.41
1.13
1.2
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
29
200
1.46
1.12
1.3
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
31
217
1.44
1.11
1.3
1.3
u/l
15.1
10.0
0.82
23
167
(3025130) Human papilloma virus identified in Specimen
15
88
1.71
1.11
1.1
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
10
51
1.97
1.11
3.4
1.8
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
26
176
1.48
1.10
1.9
2.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
96
793
1.22
1.10
2.4
2.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
21
2.38
1.09
1.0
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
23
152
1.52
1.09
2.4
2.2
ml
885.1
664.4
—
10
96
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
198
2239
0.87
1.08
10.7
7.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
55
426
1.30
1.08
2.1
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
41
545
0.75
1.06
1.7
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
59
463
1.28
1.05
1.4
1.6
iu/ml
0.3
12.6
—
9
96
(3019150) Specific gravity of Urine by Refractometry
322
3526
0.90
1.05
3.9
4.6
kg/l
1.0
1.0
0.02
43
534
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
33
237
1.40
1.05
1.1
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
43
323
1.34
1.04
3.0
3.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
28
195
1.44
1.04
2.7
3.7
%
61.2
57.6
0.39
19
133
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
9
47
1.92
1.02
1.4
1.2
—
—
—
0
0
(4034850)
40
529
0.75
1.01
11.1
10.9
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
53
413
1.29
1.01
2.8
2.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
33
239
1.39
1.00
1.3
1.3
iu/l
37.3
32.7
0.28
28
201
(3021879) Hepatitis B virus core Ab [Presence] in Serum
98
820
1.21
1.00
1.2
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
333
0.69
1.00
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
150
1303
1.16
1.00
1.4
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
48
1.88
1.00
2.1
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
35
2.00
1.00
1.0
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
35
2.00
1.00
1.0
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
18
115
1.57
0.99
2.6
2.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
43
326
1.33
0.99
3.0
3.4
%
57.4
59.3
0.49
43
326
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
23
2.18
0.98
1.0
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
169
1485
1.15
0.98
2.8
2.1
nmol/l
394.1
375.2
0.63
160
1348
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
36
1.95
0.97
1.0
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
36
267
1.36
0.96
1.1
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
56
443
1.27
0.96
2.0
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
14
222
0.63
0.95
1.6
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
88
734
1.21
0.94
1.9
1.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
24
340
0.70
0.94
2.3
1.3
e6/l
84.1
661.2
1.10
18
279
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
24
340
0.70
0.94
2.2
1.3
e6/l
8.1
39.2
1.01
15
265
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
194
1726
1.14
0.94
1.4
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
467
4362
1.09
0.94
1.6
1.6
mmol/l
1.4
1.3
0.63
388
3603
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
35
260
1.35
0.93
1.2
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
33
243
1.36
0.93
1.2
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
25
175
1.43
0.93
1.4
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
79
654
1.22
0.92
2.1
2.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
580
5474
1.09
0.92
2.0
2.2
u/l
186.6
217.2
0.56
543
5116
(3051651) Icteric interference index of Serum or Plasma
16
102
1.57
0.90
3.3
3.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
40
306
1.31
0.89
1.2
1.4
—
—
—
0
0
(3019225) pH of Specimen
209
1877
1.13
0.89
4.5
4.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
15
95
1.58
0.87
3.9
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
15
95
1.58
0.87
3.9
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
15
95
1.58
0.87
3.9
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
15
95
1.58
0.87
3.9
1.8
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
43
1.86
0.87
3.0
1.6
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
8
43
1.86
0.87
3.1
2.1
%
9.8
7.9
—
8
36
(3006184) Hemoglobin [Mass/volume] in Capillary blood
54
433
1.25
0.85
1.6
2.3
g/l
124.5
127.6
0.32
43
324
(4306422)
24
170
1.42
0.85
1.3
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
12
190
0.63
0.83
1.1
1.1
—
14.1
—
0
8
(3005570) Glucose [Moles/volume] in Urine
25
180
1.39
0.82
1.6
2.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
20
138
1.45
0.81
1.2
1.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
50
400
1.26
0.81
2.8
2.9
mg/l
1.9
1.8
0.52
44
357
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
24
172
1.40
0.81
1.2
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
2.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
24
327
0.73
0.78
1.3
1.3
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
27
0.00
0.77
0.0
1.7
—
4.8
—
0
13
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
61
503
1.22
0.77
1.8
3.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
29
217
1.34
0.77
1.5
1.7
g/l
0.9
1.0
0.08
22
166
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
67
1.65
0.75
1.5
1.7
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
24
2.09
0.74
1.2
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
61
506
1.21
0.73
2.1
3.3
mmol/l
23.9
25.1
1.35
54
435
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
132
0.60
0.73
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
16
108
1.49
0.73
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
16
108
1.49
0.73
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
16
108
1.49
0.73
1.2
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
25
2.00
0.72
1.2
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
107
0.56
0.72
1.2
1.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
64
535
1.20
0.72
2.3
2.7
g/l
0.0
0.0
0.00
58
496
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
32
247
1.30
0.70
1.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
20
143
1.40
0.70
1.2
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
30
230
1.31
0.69
1.0
1.2
u/ml
278.5
294.6
0.12
12
131
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
13
85
1.53
0.69
7.2
6.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
61
1.64
0.68
1.9
2.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
61
1.64
0.68
1.9
2.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
69
1.60
0.68
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
16
110
1.46
0.68
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
16
110
1.46
0.68
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
16
110
1.46
0.68
1.2
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
22
161
1.37
0.68
1.3
1.4
%
42.7
30.0
0.71
12
104
(3010144) Erythrocytes [#/volume] in Synovial fluid
23
170
1.36
0.67
1.4
1.3
e6/l
307779.7
116615.1
0.32
14
119
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
26
340
0.76
0.67
1.5
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
59
494
1.20
0.66
1.3
1.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
28
1.79
0.66
1.2
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
189
1727
1.10
0.63
2.1
2.5
ug/l
3.5
7.0
9.83
160
1515
(21494755) Public health laboratory ask at order entry panel
54
642
0.84
0.62
1.3
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
206
2236
0.91
0.61
4.6
4.8
%
35.0
33.4
1.19
128
1447
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
19
256
0.74
0.61
1.8
2.4
mg/l
15.0
25.2
—
5
59
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
13
88
1.48
0.60
1.2
1.1
u/l
51.3
28.8
—
8
60
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.9
—
1.6
—
0
13
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
16
220
0.72
0.59
1.5
1.5
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
8
54
1.48
0.57
1.0
1.1
—
13.4
—
0
10
(3021901) Oxygen saturation in Capillary blood
45
375
1.20
0.56
1.9
3.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
78
682
1.15
0.55
2.1
1.8
u/l
40.4
39.1
0.18
73
588
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
65
1.54
0.55
4.0
2.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
10
65
1.54
0.55
2.7
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
148
0.67
0.55
3.3
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
40
330
1.22
0.55
1.6
1.6
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
39
1.54
0.53
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
39
1.54
0.53
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
39
1.54
0.53
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
39
1.54
0.53
1.2
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
34
277
1.23
0.52
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
46
387
1.19
0.52
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
46
387
1.19
0.52
1.2
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
21
271
0.77
0.52
1.3
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
39
323
1.21
0.52
1.3
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
107
961
1.12
0.52
2.1
1.8
g/l
2.1
1.6
0.39
96
864
(3022621) pH of Urine by Test strip
126
1143
1.11
0.51
3.2
3.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
11
75
1.47
0.50
4.8
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
11
75
1.47
0.50
4.8
1.9
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
41
1.46
0.50
4.7
2.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
10
67
1.50
0.49
2.0
1.7
ug/l
63.6
51.6
—
10
62
(3032773) Endomysium IgG Ab [Titer] in Serum
14
101
1.39
0.49
1.1
1.0
—
—
—
0
0
(44813793)
12
84
1.43
0.49
1.2
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
18
136
1.33
0.49
1.1
1.1
u/ml
0.3
2.3
—
5
51
(40768446) Kidney Pathology biopsy report
7
45
1.56
0.49
1.4
1.7
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
45
1.56
0.49
1.0
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
19
145
1.31
0.48
1.2
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
107
0.65
0.48
2.1
2.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
20
154
1.30
0.48
4.0
3.1
mg/l
85.8
26.9
0.95
14
118
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
21
163
1.29
0.48
1.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
27
217
1.25
0.48
3.3
4.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
206
1921
1.08
0.48
1.3
1.3
titre
590.4
534.1
0.13
46
445
(3027008) Opiates [Presence] in Urine
19
146
1.30
0.47
1.2
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
68
1.47
0.47
1.0
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
27
218
1.24
0.46
1.1
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
16
210
0.76
0.46
1.4
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
31
255
1.22
0.45
1.1
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
11
77
1.43
0.45
4.8
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
19
147
1.30
0.45
1.2
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
25
308
0.81
0.44
2.2
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
15
112
1.34
0.44
2.9
2.0
min
475.1
496.0
—
7
79
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
44
511
0.86
0.43
1.4
1.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
49
424
1.16
0.43
1.8
2.0
mg/l
11.1
12.2
0.46
43
386
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
250
2363
1.07
0.42
1.3
1.2
u/ml
25.0
15.0
0.76
84
833
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
13
96
1.36
0.41
1.5
1.8
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
8
58
1.38
0.41
1.3
2.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
18
228
0.79
0.41
1.2
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
33
1.52
0.41
1.2
1.5
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
15
114
1.32
0.40
2.5
3.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.8
—
14.8
—
0
17
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.4
—
14.1
—
0
17
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
17
0.00
0.40
0.0
1.2
—
8.7
—
0
11
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
131
1210
1.09
0.40
3.4
3.7
kpa
5.0
5.2
1.74
123
1122
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
20
159
1.26
0.40
2.4
2.2
u/field
3.6
2.1
—
5
57
(3035611) Eosinophils/100 leukocytes in Synovial fluid
0
18
0.00
0.40
0.0
1.3
—
0.2
—
0
11
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
12
88
1.37
0.40
2.9
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
28
232
1.21
0.40
1.2
1.3
u/ml
104.2
130.8
—
5
41
(40757494) Bilirubin.total [Moles/volume] in Blood
7
101
0.69
0.39
3.4
1.9
—
42.3
—
0
6
(44806420)
8
61
1.31
0.39
2.8
2.4
—
—
—
0
0
(3009343) pH of Capillary blood
129
1192
1.09
0.39
3.3
3.7
ph
7.4
7.4
0.20
23
160
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
97
1.34
0.39
1.1
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
124
1145
1.09
0.38
3.2
3.7
mmol/l
2.4
2.0
0.37
86
848
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
32
271
1.18
0.37
1.1
1.3
—
19.0
—
0
6
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
116
1.30
0.37
1.3
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
19
234
0.81
0.36
1.4
1.4
e6/l
553021.7
83945.5
0.63
12
133
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
5
77
0.65
0.35
1.2
1.5
%
66.1
63.1
—
5
60
(3000093) Morphology [Interpretation] in Blood Narrative
20
162
1.24
0.35
1.1
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
13
99
1.32
0.35
3.2
2.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
29
245
1.19
0.35
2.2
2.6
—
—
—
0
0
(3017704) Immunofixation for Urine
9
125
0.72
0.35
1.8
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
44
1.36
0.34
1.0
1.0
miu/ml
1699.0
1538.2
—
6
44
(3022689) Creatine [Moles/volume] in Urine
6
44
1.36
0.34
1.2
1.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
11
82
1.34
0.34
1.5
1.4
nmol/l
0.1
0.2
—
5
62
(40768800) Prostate Pathology biopsy report
46
406
1.14
0.33
1.1
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
50
444
1.13
0.33
1.7
1.6
e6/l
7639.4
15063.9
1.77
36
325
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
144
0.76
0.33
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
87
0.69
0.33
1.2
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
89
0.67
0.33
1.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
74
1.35
0.32
2.7
2.6
u/ml
1018.9
1414.5
—
10
74
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
6
47
1.28
0.32
1.0
1.0
pmol/l
230.7
281.6
—
6
33
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
85
780
1.09
0.32
1.1
1.1
iu/ml
143.2
145.8
0.02
25
272
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
139
1482
0.93
0.32
1.5
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
13
101
1.29
0.31
1.9
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
32
369
0.86
0.31
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
18
147
1.23
0.30
2.2
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
10
75
1.34
0.30
2.3
3.0
u/l
208.0
209.2
—
10
75
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
15
120
1.25
0.30
1.2
1.3
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
14
111
1.26
0.30
1.1
1.2
mmol/l
1.9
2.1
0.58
14
104
(3037756) Immunofixation for Serum or Plasma
51
458
1.12
0.29
1.7
1.6
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
7
56
1.25
0.29
7.3
7.8
mmol/l
24.2
25.0
—
7
50
(3004616) Nuclear Ab [Presence] in Serum
17
206
0.82
0.29
1.3
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
128
1203
1.07
0.28
2.5
2.8
g/l
11.5
10.7
0.75
117
1091
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
15
121
1.24
0.28
1.0
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
45
403
1.12
0.28
1.6
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
116
0.77
0.27
1.1
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
121
0.74
0.27
2.2
2.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
22
187
1.18
0.26
1.3
1.2
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
8
67
1.19
0.26
1.1
1.3
mmol/l
2.7
3.1
—
8
59
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
11
86
1.28
0.26
1.9
1.7
nmol/l
19.2
16.2
0.75
11
78
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
73
0.68
0.26
1.0
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
72
779
0.92
0.26
1.3
1.3
u/ml
198.7
202.4
0.03
64
709
(21494890) Protein electrophoresis panel - 24 hour Urine
25
216
1.16
0.25
2.0
2.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
68
627
1.09
0.25
1.2
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
50
454
1.10
0.25
2.7
2.3
ug/min
116.9
94.0
0.09
27
273
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
76
1.19
0.24
1.2
1.9
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
12
96
1.25
0.24
1.3
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
18
152
1.19
0.23
1.3
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
34
303
1.12
0.23
5.9
5.0
iu/ml
260.0
951.7
—
6
41
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
92
0.76
0.22
1.0
1.1
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
5
41
1.22
0.22
1.0
1.2
g/l
0.3
0.3
—
5
31
(3036071) Salmonella sp Ab [Titer] in Serum
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
42
382
1.10
0.21
1.6
1.6
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
11
0.00
0.21
0.0
2.0
—
1.7
—
0
11
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.5
—
21.3
—
0
6
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
90
847
1.07
0.21
3.1
3.2
pmol/l
4.3
4.4
0.32
76
729
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.4
—
37.3
—
0
6
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
12
98
1.23
0.21
3.3
3.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
43
1.16
0.21
1.4
1.5
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
20
173
1.16
0.21
1.2
1.2
—
80.5
—
0
7
(44790048)
17
198
0.86
0.20
1.3
1.5
—
—
—
0
0
(44790049)
17
198
0.86
0.20
1.3
1.5
—
—
—
0
0
(44790047)
17
198
0.86
0.20
1.3
1.5
—
—
—
0
0
(44806118)
17
198
0.86
0.20
1.3
1.5
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
48
1.25
0.20
1.7
1.9
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
6
50
1.20
0.19
1.0
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
184
1.14
0.19
3.2
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
81
858
0.94
0.18
4.1
3.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
162
1682
0.96
0.18
1.2
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
30
331
0.90
0.17
1.6
1.8
iu/l
7.3
4.7
—
8
101
(3037556) Urate [Mass/volume] in Serum or Plasma
5
67
0.75
0.17
1.0
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
69
0.72
0.17
1.0
1.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
8
69
1.16
0.16
1.0
1.2
—
72.7
—
0
9
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
18
158
1.14
0.16
3.4
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
18
158
1.14
0.16
3.4
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
18
158
1.14
0.16
3.4
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
192
0.88
0.14
3.2
2.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
83
1.08
0.14
1.2
1.1
—
—
—
0
0
(4094501)
46
430
1.07
0.14
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
39
363
1.08
0.14
1.3
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
122
1.15
0.13
1.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
97
0.82
0.13
1.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
8
98
0.82
0.13
28.8
11.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
44
413
1.07
0.13
1.5
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
169
0.89
0.12
1.4
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
23
250
0.92
0.11
4.9
2.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
25
231
1.08
0.10
1.4
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
177
0.90
0.10
1.2
1.1
—
—
—
0
0
(4146454)
20
218
0.92
0.10
2.0
2.6
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
5
44
1.14
0.10
1.0
1.2
—
12.1
—
0
7
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
12
135
0.89
0.09
1.2
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
135
1.11
0.09
1.5
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
76
787
0.96
0.09
1.7
1.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
18
196
0.92
0.09
1.1
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
21
194
1.08
0.09
3.2
1.7
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
6
55
1.09
0.09
1.3
1.3
%
10.3
22.1
—
6
44
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
57
1.05
0.08
1.0
1.2
iu/ml
678.3
258.8
—
6
57
(3045142) Bone marrow Pathology biopsy report
20
216
0.93
0.08
1.3
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
62
0.81
0.08
1.4
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
40
381
1.05
0.08
1.2
1.2
u/ml
3.7
4.5
—
7
43
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
65
0.77
0.08
1.6
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
7
64
1.09
0.08
1.1
1.1
—
462.5
—
0
17
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
10
88
1.14
0.08
3.6
2.0
e6/l
701.4
693.1
—
5
41
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
65
1.08
0.08
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
66
1.06
0.08
1.3
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
7
68
1.03
0.07
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
133
0.90
0.07
1.1
1.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
6
70
0.86
0.07
1.8
1.4
—
0.3
—
0
9
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
13
143
0.91
0.07
1.4
1.4
u/l
13.5
13.8
0.08
13
136
(3019420) Tryptase [Mass/volume] in Serum or Plasma
8
78
1.03
0.07
1.3
1.5
ug/l
6.9
10.8
—
8
67
(3012565) Volume of 24 hour Urine
7
84
0.83
0.07
2.6
2.7
ml
1540.0
1799.0
—
7
74
(3017315) Amylase [Enzymatic activity/volume] in Urine
9
88
1.02
0.07
1.3
1.2
u/l
161.0
311.2
—
9
80
(3003181) Sodium [Moles/volume] in Urine
39
374
1.04
0.06
1.1
1.4
mmol/l
53.3
59.3
0.76
23
307
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
22
207
1.06
0.06
5.2
3.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
17
158
1.08
0.06
1.2
1.1
u/ml
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
119
1.09
0.06
1.1
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
11
121
0.91
0.06
1.2
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
131
0.92
0.05
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
41
425
0.96
0.05
1.6
1.7
mg/l
4.6
2.9
0.50
32
323
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
15
139
1.08
0.05
1.7
1.6
u/ml
16.0
24.4
—
5
25
(3039443) Prostate specific Ag panel - Serum or Plasma
25
262
0.95
0.04
1.6
1.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
74
756
0.98
0.04
1.2
1.2
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
21
200
1.05
0.03
1.1
1.4
mmol/l
7.3
6.6
0.36
21
190
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
87
884
0.98
0.03
1.4
1.3
au/ml
63.5
53.6
—
6
37
(3024891) Influenza virus A+B Ag [Presence] in Specimen
35
361
0.97
0.03
1.2
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
40
389
1.03
0.03
1.2
1.2
u/ml
1.7
7.2
—
8
71
(3042631) Mycobacterium sp identified in Specimen
26
270
0.96
0.03
1.9
2.6
—
—
—
0
0
(1002224) Polysomnography panel
41
421
0.97
0.03
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
18
171
1.05
0.03
2.2
1.3
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
14
148
0.95
0.02
1.3
1.2
u/l
10.0
12.4
0.72
14
136
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
113
1.06
0.01
1.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
39
398
0.98
0.01
3.6
3.9
mg/l
24.4
27.0
0.23
24
249
(4024509)
17
177
0.96
0.01
1.5
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
16
154
1.04
0.00
1.8
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
20
206
0.97
0.00
1.1
1.2
miu/ml
230.0
208.5
—
6
67
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
44
446
0.99
0.00
1.7
1.5
g/l
1.1
1.2
1.14
44
423
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
46
454
1.01
0.00
2.3
1.7
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
15
145
1.03
0.00
1.3
1.1
—
64.0
—
0
7
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
99
1.01
0.00
1.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
99
1.01
0.00
1.0
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
12
124
0.97
0.00
1.1
1.2
—
143.0
—
0
20
(3026389) Candida sp identified in Specimen by Organism specific culture
21
206
1.02
0.00
1.2
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
25
254
0.98
0.00
1.2
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
73
728
1.00
0.00
4.2
4.0
mmol/l
25.1
24.9
0.17
63
677
(4010399)
122
1222
1.00
0.00
1.5
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
19
192
0.99
0.00
1.7
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
13
128
1.02
0.00
1.1
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
35
347
1.01
0.00
1.5
1.5
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
2.7
—
0
7
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
88
0.91
0.00
1.0
1.2
nmol/l
157.5
142.2
—
8
88
(3043722) Hyaline casts [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
1.0
—
1.0
—
0
5
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
7
77
0.91
0.00
4.0
4.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
92
0.98
0.00
3.3
3.6
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
64
0.94
0.00
1.3
1.1
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.4
—
4.7
—
0
5
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
56
0.89
0.00
1.0
1.1
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
9
89
1.01
0.00
1.4
1.4
g/l
0.9
1.0
—
9
89
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
66
0.91
0.00
1.3
1.2
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
56
0.89
0.00
1.0
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
6.3
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
5.2
—
0
6
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
0.00
0.0
8.8
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
30
300
1.00
0.00
1.5
1.5
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.5
—
397.5
—
0
8
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
74
0.95
0.00
1.0
1.2
—
—
—
0
0
(4211845)
8
83
0.96
0.00
3.6
4.2
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
6
0.00
0.00
0.0
1.2
—
7.6
—
0
6
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
5.0
—
385.3
—
0
6
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
58
0.86
0.00
1.2
1.4
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
2.4
—
0
5
(3011325) HIV 1+2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: OPER_JFB31 – Laparoscopic right hemicolectomy

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).